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1INTRODUCTION
Hypertensive disorders in pregnancy affects approximately 15% to
20% of all woman worldwide. The incidence is higher in western
population and in woman belonging to high socio economic class. The
incidence of gestational hypertension is on rise, which is highly attributed
to life style changes, increased work stress, junk foods, and so on.
Hypertensive disorders in pregnancy may be a sequelae of chronic
hypertension (which exists even prior to pregnancy) or the ones which
develop for the first time during pregnancy especially in the late second
trimester. The severity of gestational hypertension varies from mild to
severe gestational hypertension and finally eclampsia. This can affect both
the mother and the fetus.
So there is a need to frame a good and effective screening test which
can be used during routine antenatal check up to predict pre-eclampsia at
the earliest. In this study, I have compared the lipid profiles of pre-
eclamptic patients with normotensive patients. Various studies have been
conducted previously on lipid profile changes in pre eclamptic female and
have had a positive association between the same.
2RESEARCH DEFINITION:
PRE ECLAMPSISA is New onset of hypertension with  BP>
140/90 mmhg after 20 weeks of pregnancy with
a) .Protineuria- >300mg/24hrs  (or) urine dipstick protein 1+.
(OR)
b) Thrombocytopenia- platelet count<1,00,000
Renal insufficiency- Creatinine >1.1mg/dl
Liver involvement- serum transaminases elevated
Pulmonary symptoms
Cerebral symptoms
3ABNORMALITY NONSEVERE SEVERE PE
DIASTOLIC BP <110mmHg >110 mmHg
SYSTOLIC BP <160mmHg >160 mmHg
PROTEINURIA + +
IMMINENT SYMPTOMS - +
SERUM CREATININE Normal Elevated
THROMBOCYTOPENIA Absent Present
FGR Absent Present
PULMONARY EDEMA Absent Present
CAUSES OF PRE ECLAMPSIA:
1. Placental implantation with abnormal trophoblastic invasion of
uterine vessels.
2. immunological maladaptative tolerance between maternal, fetal,
placental tissues.
3. Maternal maladaptation to cardiovascular & inflammatory changes
of pregnancy.
4. Genetic factors including predisposing genes and epigenetic
influences.
4RISK FACTORS:
1. RACE & ETHNICITY:
Incidence of pre-eclampsia is 5% in whites, 9% in Hispanics, 11%
in African American women.
2. AGE:
Young primi <20yrs, all patients > 35years have increased chances
of pre eclampsia.
3. PARITY:
Primigravida have 15% more chances of pre eclampsia than
multigravida.
4. FAMILY HISTORY:
Inheritance is three times increased if there is a affected first degree
relative.
5. PREVIOUS HISTORY OF PRE ECLAMPSIA:
Women with pre elampsia in first have greater chances of
recurrences in subsequent pregnancy.
56. WEIGHT:
Relationship between maternal weight & preeclampsia is
progressive. It increases from 4.35% in women with BMI<20kg/m2 to
13.3% in women with BMI>35kg/m2.
7. MULTIPLE PREGNANCY:
Women with multiple pregnancy have 13% increased incidence of
pre-eclampsia compared to 5% in singleton pregnancy.
8. DIET:
Deficiency in dietary calcium & vitamin C have increased incidence
of pre eclampsia.
9. HYDATIDIFORM MOLE:
In large rapidly growing mole there is increased chances of pre-
eclampsia.
10. RENAL DISEASE:
20% OF pre eclampsia occurs in pre existing renal disease patients.
611. THROMBOPHILIA:
Utero placental thrombosis is frequently associated with pre-
eclampsia.
PATHOGENESIS:
Pre-eclampsia occurs only in pregnancy but it also occurs in
pregnancy lacking fetus like molar pregnancy and in abdominal
pregnancies suggesting that it is the presence of trophoblastic tissue that
provides the stimulus for the disease. It’s a two stage disease process
which originates early in pregnancy:
FIRST STAGE:
Trophoblast invasion is patchy and spiral arteries retain their
muscular walls. It prevents development of high flow, low impedance
circulation and leads to uteroplacentl ischemia.
SECOND STAGE:
Uteroplacental ischemia results in oxidative and inflammatory
stress with involvement of secondary mediators of inflammation leading
7to endothelial dysfunction, vasospasm and activation of coagulation
system.
IMMUNOLOGIAL MECHANISM:
Genetic predisposition
Abnormal trophoblast invasion
Hypoperfused placenta
Circulating factors
Vascular and endothelial cell activation
8There is increasing evidence both from animal and human studies
that there is imbalance between angiogenic and anti angiogenic factors in
pre eclampsia.
PATHOPHYSIOLOGY:
Pre eclampsia is a multi organ involvement with characteristic
features in each organ system. The changes are either due to high blood
pressure or diue to its effects like vasospasm, ischemia, endothelial
dysfunction.
CARDIOVASCULAR SYSTEM:
The manifestation of pre-eclampsia are
a) Increased cardiac afterload
b) Endothelial activation with inter endothelial extravasation of
intravascular fluid into extra vascular space.
c) Hyperdynamic ventricular function.
d) Increased peripheral resistance
e) Pulmonary edema due to alveolar endothelial – epithelial leak that
is compounded by low oncotic pressure.
9RENAL SYSTEM:
Following changes are noted as a consequence of Preeclampsia in
kidney which are reversible
a) Glomerular capillary endotheliosis- glomeruli are enlarged and
distended. Electron microscopy reveals endothelial cell
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hyperplasia, exudation of macrophages, leucocytes into
mesangium.
b) Focal segmental glomerulosclerosis
c) Nephrotic range of proteinuria
d) Acute tubular necrosis- usually reversible, occurs due to
hypotension and hypovolemia in severe disease in association with
obstetric hemorrhage.
e) Elevated GFR
f) Increased urinary sodium
g) Decreased urinary calcium due to increased reabsorption
LIVER:
Pathophysiological changes include ischemia, infarction and
hemorrhage. It results in upper epigastric pain or right quadrant pain and
tenderness usually in severe disease. Microscopic changes related to pre
eclampsia in liver are 1. Periportal hemorrhage
2. Hepatic hematoma
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BRAIN:
Vasospasm and vasodilatationare both seen in pre eclampsia in
cerebral arterioles. Due to severe hypertension there is vasoconstriction
leading on to ischemia, cytotoxic edema and infarction. Once the
regulatory mechanism fails there comes hyperperfusion and vasogenic
edema. Common changes seen in brain are
a) Neurogenic edema
b) PRES
c) Blindness
d) Cerebral edema
e) Cerebral hemorrhage
f) Supra tentorial herniation
g) Foci of infarction
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UTEROPLACENTAL CIRCULATION:
Compromised uteroplacental perfusion leads to increased perinatal
mortality. The following Doppler abnormalities are seen during
evaluation of pregnant mothers
a) Notching in uterine artery
b) Decreased placental vascularity index- Normal-15%, in pre-
eclampsia it is 11.1%.
c) Increased resistance in spiral arteries.
13
PLACENTA:
There is increased incidence of infarcts, hematoma, congested
chorionic villi, proliferative endarteritis and degeneration in placenta
compared to normal placenta,. These changes are proportional to degree
of severity. Microscopic examination reveals
a) Increased syncytial knots
b) Fibrinoid necrosis
c) Endothelial proliferation
d) Calcified and hyaline villous spaces.
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COAGULATION SYSTEM:
Intravascular coagulation and erythrocyte destruction are consistent
with pre-eclampsia. Increased factor 7 consumption and decreased anti
thrombin 3, protein C &S are noted. Increased fibrinogen levels if
associated with abruption. Fibronectin a glycoprotein linked to basement
membrane is also found to be elevated in pre-eclampsia.
Findings pertaining to coagulation system in pre-eclampsia:
a) Thrombocytopenia
b) Elevated LDH
c) Increased coagulation factors
EYE:
Scotoma, blindness, diplopia commonly occurs during severe pre
eclampsia. These symptoms usually resolves with anti hypertensive drugs
and magnesium sulphate. Blindness usually arise from infarction of three
susceptible areas in brain like occipital lobe, lateral geniculate nuclei and
brain.
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Occipital blindness usually occurs due to vasogenic edema. Rarely
cerebral infarctions result in partial or total visual defect. Blindness from
16
retinal lesions usually occurs due to serous retinal detachment or retinal
infarction called by a special name PURTSCHER RETINOPATHY.
PREDICTIVE TESTS FOR PRE ECLAMPSIA:
1) PLACENTAL PERFUSION/ VASCULAR RESISTANCE-
Roll over test - measures hypertensive response in women who
are resting in decubitus position and then roll over to supine
position. Increased blood pressure signifies positive test.
Cold pressor test – is a cardiovascular test performed by
immersing hand into cold water for one minute and measuring changes in
blood pressure and heart rate. Sensory afferent nerve triggers sympathetic
activation leading to vasoconstriction. This results in elevated pulse
pressure due to catecholamine release.
Isometric handgrip test - it activates mechanoreceptors due to
increased muscle tension. It increases the excitatory state of the
central nervous system and results in increase in sympathetic
outflow and decrease in parasympathetic outflow thereby increase
in blood pressure response.
Mid trimester Mean arterial pressure – Normal is 65-110mmHg.
It is used similar to systolic blood pressure to monitor and treat
17
patients. Patients with MAP > 90mmHg is associated with higher
risk of pre-elampsia
Uterine artery Doppler – Doppler interrogation of uterine artery
shows end diastolic velocity and end diastolic notch. Notching is
defined as a fall of atleast 50cm/sec from maximum diastolic
velocity. It should be performed between 22 to 24 weeks of
gestation. Notching demonstrates low positive predictive value for
pre-eclampsia but 97% negative predictive value in high risk
population. Predictive testing model including maternal
factors,uterine artery pulsatality index in first trimester and change
in pulsatality index between first and second trimester have a
detection rate of 96%.
24 hours ambulatory BP measurement – helps to diagnose
gestational hypertension at the earliest. It is a more sensitive
predictor of cardiovascular outcome than conventional BP
measurement. During daytime, more than fourteen measurements
and at night time seven measurements are made.
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2) RENAL DYSFUNCTION:
Uric acid – Increased serum uric acid in pre-eclampsia is likely
to be influenced by changes in maternal renal function like decreased
tubular reabsorption and increased production. Also placenta and fetus
play a role in uric acid elevation. Hypoxia induced change in
production of xanthine oxidase/ dehydrogenase.so uric acid may be a
better marker of poor placental perfusion and fetal hypoxia.
Microalbuminuria - Urinary protein values of more than
300mg/24hrs or urinary dipstick values of more than 1+ suggest
significiant protein excretion in pregnancy. Acute onset of
proteinuria and worsening of proteinuria is a marker of poor
maternal outcome in pregnant hypertensive mothers.
Urinary calcium/kallikrein
Microtransferrineuria
Fasting urine albumin/creatinine ratio
3) FETAL PLACENTAL UNIT:
Human chorionic gonadotrophin
Alpha feto protein
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Pregnancy associated placental protein A
Placental protein 13
Inhibin
Marker Mechanism of action
Levels associated
with PE
PAPPA-A
Insulin like growth
factor binding protein
protease: impaired
trophoblast invasion
and fetal cell growth

PIGF
Vascular endothelial
growth factor
trophoblastic
implantation

sFlt-1 Antiangiogenic factor 
Inhibin A & B
Maintenance of spiral
artery

sEng
Impairs binding of
transforming growth-

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1 to cell surface
receptors, inhibiting
angiogenesis
PP13
Binds to protein on
extracellular matrix
between placenta and
myometrium: placenta
implantation &
remodeling

ADAM12
Placenta derived
multidomain
glycoprotein: fetal &
placental growth

4) ENDOTHELIAL DYSFUNCTION/ OXIDATIVE STRESS:
Platelet count
Antiphospholipid antibody
Lipid profile
Fms like tyrosine kinase receptor-1
Homocysteine
21
Beta2 microglobulin
Fibronectin
VEGF, PIGF.
Endoglin
Cell adhesion molecules
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5) Genetic markers
The candidate genes selected to predict pre eclampsia are
a) MTHR- Methylene tetra hydrofolate reductase
b) F5- factor 5 leiden
c) AGT- angiotensinogen
d) ACE- Angiotensin converting enzyme
e) SERPINE 1- Serine peptidase inhibitor
f) LPL- lipoprotein lipase
g) NOS 3- nitric oxide synthetase
h) F2- Prothrombine
6) Cell free DNA- Due to increased maternal and fetal trafficking in
pre-eclampsia there is more number of fetal cells detected in
maternal blood which can be studied to predict hypertensive
disorders earlier in pregnancy.
23
Though a lot of tests have been studied so far, no tests is found to
better and cost effective in predicting pre-eclampsia. BMI, Alpha
fetoprotein, fibronectin, uterine artery Doppler seemed to have a good
specificity of 90% but poor sensitivity. Many tests should come to predict
pre eclampsia in early pregnancy sonthat there will be a better perinatal
and maternal outcome.
24
METHODS TO PREVENT PRE ECLAMPSIA:
Few methods used to prevent or modify the severity of pre-
eclampsia are
1) Dietary modification :
Salt restriction
Calcium supplementation
Fish oil supplementation
Arginine supplementation
Increased protein intake
Change in dietary habits
2) Exercise :
Physical activity
Stretching
Aerobic exercise
3) Cardiovascular drugs :
Diuretics
Anti hypertensive drugs
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4) Anti thrombotic drugs
Low dose aspirin used for a better perinatal outcome.50-
150mg/day is advised as it selectively inhibits TX-A2 synthesis
with minimal effect on prostacycline. CLASP (Collabrative low
dose aspirin) study is the largest conducted so far to prove the
efficacy of aspirin in reducing the morbid effects of pre elampsia.
5) Magnesium, Folic acid, Vitamin B Supplementation
6)Heparin in women with anti phospholipid syndrome.
7)ANTI OXIDANTS: Vitamin C, E, lycophene,N acetyl cysteine,
garlic supplementation in preventing pre eclampsia as studied by a
Cochrane review in 2008.
7) Bed rest.
8) Control of body weight
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LIPID METABOLISM IN PREGNANCY:
Abnormal lipid profile is known to be strongly associated with
atherosclerotic cardiovascular disease and has a direct effect on
endothelial cell activation. Abnormal lipid metabolism seems to be
important in the pathogenesis of preeclampsia too.
Normal      human     pregnancy results     in      a pronounced
physiologic hypertriglyceridemia involving a gestational rise in blood
triglycerides and cholesterol. Serum triglycerides and LDL concentrations
in women with preeclampsia were higher than those in women with
uncomplicated pregnancy.
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During the first trimester there is increased maternal fat
accumulation (anabolic state) is presumed to be important for the
subsequent hypertriglyceridemia normally occurring in later gestation
(catabolic state). Circulatory concentrations of VLDL & LDL normally
increase with gestational age as reflected by marked increases in serum
triglycerides and cholesterol. The hypertriglyceridemia is due primarily to
enhanced entry of triglyceride rich lipoproteins (especially VLDL) into
the circulation rather than to diminished removal. Estrogen may play a
major role in the  lipoprotein  patterns seen  in  human  pregnancy
although  LDL cholesterol  is  more  influenced  by  the  combined  effect
of  increased  estrogen and progesterone. Additionally placental
lipoprotein lipase activity normally  increases  as term approaches.
The mechanisms driving the abnormal elevation in triglycerides and
free fatty acids  in  preeclampsia  are  unclear  metabolic  patterns
resembling  ` Syndrome  X’ or `Insulin Resistance Syndrome’. Heightened
insulin resistance occurring in preeclampsia would increase fatty acid
mobilisation from the visceral fat, promote overproduction of VLDL by
the liver and suppress activity of posthepatic lipoprotein lipase resulting
in elevated serum free fatty acids and triglycerides.
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MECHANISM BEHIND LIPID METABOLISM:
1. Enhanced lipolysis in adipose tissue facilitating availability of
substrates for Triglyceride synthesis and VLDL influx into circulation.
2. Increased chylomicron formation from dietary lipids.
3. Reduced lipoprotein lipase activity in extrahapatic tissues resulting in
decreased triglyeride removal
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COMPONENTS OF LIPID PROFILE:
Lipid profile or lipid panel includes the following components:
1. Total cholesterol
2. Triglycerides
3. LDL
4. HDL
5. VLDL
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Testing lipid profiles require about 9-10 hours of fasting initially.
But now most of the labs use non fasting state to test it without affecting
the efficacy of results.
Fasting blood samples are analysed for total cholesterol,
triglyceride, HDL by enzymatic methods using semi auto analyser.
Serum LDL cholesterol value is calculated by FREDERICKSON –
FRIEDWALD formula .According to this,
LDL = Total cholesterol – ( HDL + VLDL )
Serum VLDL is calculated by dividing triglyceride by five
Using these values ,we can make TC/HDL, TGL/HDL, HDL/LDL ratios
which can be used to assess dyslipidemia,.
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REVIEW OF LITERATURE
Carl Hubel et al., (1995) in their study, concluded that triglycerides
and fatty acids, but not cholesterol, are increased in preeclampsia and
correlate with the lipid peroxidation metabolite malondialdehyde 5. These
interactions contribute to endothelial cell dysfunction in preeclamptic
patients.
Ray  et al., (2006) studied the risk of preeclampsia  in the presence
of maternal triglyceridemia, another major element of the metabolic
syndrome.24 A total of 19 case control and 3 prospective cohort studies
were included. In 14 studies, the mean TGL concentration was
significantly higher among preeclamptic cases than among unaffected
controls. In seven other studies, there was a nonsignificant trend in the
same direction. The risk of preeclampsia typically doubled with each
increasing TGL category. In the four studies, that adjusted for potential
confounders, such as maternal age, parity and body mass index, there was
a four fold higher risk of preeclampsia in the highest relative to the lowest
triglyceride category.
Thus, the study  concluded  that there exists  a  consistent  positive
association between elevated  maternal triglycerides  and  the  risk  of
preeclampsia.  Given  that maternal hypertriglyceridemia is a common
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feature of the metabolic syndrome, interventional studies are needed to
determine whether pre-pregnancy weight reduction and dietary
modification can lower the risk of preeclampsia.
Sattar et al., (2002) studied the involvement of lipids in the
pathophysiology of preeclampsia by doing lipid profile and lipoprotein
subfactors in preeclampsia and in normal pregnancy.25 They showed the
potential links of the atherogenic lipid profile in preeclampsia to oxidative
pathways, endothelial dysfunction and vascular inflammation.
Manten et al., (2004) studied the role of lipids in the endothelial cell
dysfunction and thus leading to preeclampsia.18 Seventy women were
recruited, 50 were nulliparous women with singleton pregnancies and not
in labour, 10 had severe preeclampsia.  20 had mild preeclampsia and 20
were healthy pregnant controls. The other 20 women were healthy non
pregnant controls. There was a tendency to higher Lipoprotein-a
concentration in women with preeclampsia. In the preeclampsia group,
the concentrations of cholesterol and triglycerides were reported to be
higher and the HDL cholesterol concentration was lower as compared to
normal pregnancy.
Gratacos et al., (2003) evaluated the susceptibility to oxidation of
LDL in women with a history of preeclampsia by a case control study.9
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Thirty five patients, who were diagnosed with severe preeclampsia  and
35  controls  were matched for  age,  BMI, smoking  and parity. Plasma
samples were analysed for total cholesterol, HDL, LDL, triglycerides  and
lipoprotein  A.  The in vitro  susceptibility  to oxidation  of  LDL was
measured and expressed in minutes.
Mean LDL cholesterol and triglyceride levels were higher in
preeclampsia group compared with  controls. The susceptibility  to
oxidation  of LDL was also significantly higher in the preeclampsia group.
Kaaja et al., (1995) and Sattar et al., (1997) have found higher
plasma TGL and low HDL concentrations  in women with  preeclampsia
and gestational  HT.12,26   Given these findings, it  had been postulated
that lipid abnormalities  could play a role in the pathogenesis of
preeclampsia, causing altered endothelial cell dysfunction and vascular
damage.
Sattar et al., (1997) studied the lipoprotein subfraction
concentrations in preeclampsia.26 They concluded that the pathogenesis
parallels to atherosclerosis.
In a recent study, in 2001, The National Heart Foundation  of
Australia  found a correlation between F2 - isoprotanes with increased
levels of total and LDL cholesterol and triglycerides and significantly
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reduced levels of HDL cholesterol in women with preeclampsia,
compared with that of  the normotensive group. Increased levels of  F2
isoprotanes show that preeclamptic subjects are under increased oxidative
stress, indicated by the increased rates of neutrophil activation.
Anceschi et al., (1992) conducted a study on erythrocyte membrane
composition in pregnancy induced  hypertension,  which is an evidence
for an altered lipid profile.1
They concluded that the cholesterol / phospholipid ratio was
significantly higher in the women with pregnancy induced hypertension
compared with the normotensive pregnant women (PIH - 1.24 compared
with  normotensive - 0.88). The increased  cholesterol / phospholipid
ratio  of  the erythrocyte membrane found in pregnancy induced
hypertension represents one factor involved in the pathophysiology of this
condition and a possible biochemical marker of the disease.
In  a  study by  Dempsey  et al.,  (2004),  maternal birth weight
was  correlated negatively  with  triglycerides  and correlated positively
with  high  density  lipoprotein cholesterol.7 Women who weighed <2500
gms at birth had higher triglyceride and total cholesterol concentration
and lower  HDL concentrations,  when compared with  women who
weighed 3000 to 3499 gms at birth. Women who were born small and
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became overweight in adulthood had less  favourable lipid profiles than
their counterparts who weighed >2500 gms at birth and remained lean.
Thus they concluded that factors that are related to growth in utero
may help to predict the subsequent risk of altered lipid metabolism during
pregnancy which may, in turn be causally related to the occurrence of
preeclampsia.
In a study by Barden et al., (1999) the aim was to identify those
factors in the non pregnant state that distinguished  women who developed
preeclampsia  from those who had normotensive pregnancies.2  The
results were : Regardless  of parity, women with preeclampsia  had
elevated BMI before, during  and after pregnancy compared with women
who had normotensive pregnancies. Triglycerides were significantly
elevated in women who had preeclampsia both before and after delivery.
The relative elevation of blood pressure, BMI and lipids in the non
pregnant state are  features of  the  metabolic  syndrome  and  may  be
important  sensitising  factors contributing to the pathogenesis of
preeclampsia. A familial predisposition to preeclampsia may operate
partly through these mechanisms.
Kokia  et al.,  (1999)  studied the maternal serum lipid  profile in
pregnancies complicated  by  hypertensive  disorders.15   Serum
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triglyceride  levels were significantly elevated in the hypertensive
patients. This elevation was not influenced by the severity or etiology of
the hypertension. The lipid  profile found in the hypertensive pregnant
patients  could  be  associated with  enhancement of  pathological  lipid
deposition  in predisposed vessels such as the uterine spiral arteries.
Further the hypertriglyceridemia found in the hypertensive patients may
be associated with the hypercoagulability reported in pregnancy induced
hypertension.
Daniel et al., (2004) investigated the relationship between early
pregnancy plasma lipid  concentration  and risk  of  preeclampsia.6   They
concluded that early  pregnancy dyslipidemia is associated with an
increased risk of preeclampsia. This association may be significant in
understanding the pathologic processes of preeclampsia  and may help in
developing strategies for prevention or early diagnosis of the disorder.
Thadhani  et al., (1999) and Bodnar et al., (2005) found an
association  between high  body mass index and hypercholesterolemia,
which in turn increases the risks of preeclampsia.28, 4
Wolf  et al.,  (2001)  showed that obesity  has a role to play  in
preeclampsia.33
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Ramsay et al., (2002) inferred that obesity is associated with
dysregulation of metabolic, vascular  and inflammatory  pathways.23
O’Brien  et al.,  (2003)  found  that increased maternal BMI increases the
risk of preeclampsia.22
Torun et al., (2001) found that dyslipidemia in early second
trimester is mainly a feature of women with  early onset pre-eclampsia.29
Hubel et al., (1998) found elevated levels of low density lipoproteins and
vascular cell adhesion molecule -1 in association with hyperlipidemia in
preeclampsia.11
Ware Jauregui et al., (1999) compared the plasma lipid
concentrations in preeclamptic and normotensive Peruvian women.32
Vanderjagt et al., (2004) found that high - density lipoprotein and
homocysteine levels correlated inversely in preeclamptic women.30
Kharba et al., (1998) determined the lipid peroxidation and vitamin
E  levels in preeclampsia.14    Maseki  et al.,  (1981)  compared the lipid
peroxide  levels  and lipid content of  serum  lipoprotein  fractions  of
normotensive  pregnant subjects  and  the subjects with preeclampsia.19
Gratacos et al., (1996) studied the variation in lipid levels during
pregnancy in women with different types of hypertension.10  Llurba et al.,
(2004) and Wakatsuki et al., (2000)  did  a  comprehensive  study  of
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oxidative  stress and the antioxidant  status in preeclampsia   and  normal
pregnancy.16,31    Granger  et  al.,  (2001)  linked  endothelial dysfunction
with placental ischaemia, leading to the pathogenesis of preeclampsia.8
Sattar et al., (1997) studied the threshold effect of plasma
triglyceride on appearance of small dense low density lipoproteins as well
as the lipoprotein subfraction changes in normal pregnancy.27 Lorentzen
et al., (1995) found the fatty acid pattern of esterified and free fatty acids
in sera of women with normal and preeclamptic pregnancy.17
Mikhail et al., (1995) showed the relationship between plasma
triglyceride levels and severity of preeclampsia.20  Khaliq et al., (2004)
studied the serum lipid and lipoproteins  in  preeclampsia  with  special
reference to parity.13   Murai  et al.,  (1997) correlated the maternal and
fetal modulators of lipid metabolism with the development of
preeclampsia.21
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AIM
To  analyse  the lipid  profile in  normal  pregnant women and the
lipid  profile changes in women with pre eclamptic mother .
40
MATERIALS AND METHODS
Study Design
Comparative Study.
Study period
September 2017 to August 2018.
Objective:
1.To analyse lipid profile changes in pre eclamptic mother.
2.TO compare the lipid profile values of normal pregnant
mother and pre eclamptic mother.
3.To establish the relationship between lipid profile changes and
pre eclampsia.
4.To know the efficacy of lipid profile in predicting pre
eclampsia.
Inclusion Criteria
1. Pregnant women in  the  third  trimester   diagnosed  as  Pre
eclampsia with   no  other associated complications.
2. Normal women in the third trimester of  pregnancy with  no other
maternal medical complications, admitted for safe confinement.
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Exclusion Criteria
 Chronic hypertension
 Pregestational Diabetes mellitus
 Nephrotic Syndrome
 Cardiac Disease.
 Hepatic Disease.
 Twin pregnancy
 Any medications except for vitamins and minerals.
 Smoking
 Alcohol abuse
 Labour contractions
 Thyrotoxicosis.
 Molar pregnancy
Methodology
All pregnant mother included in the study are subjected to
detailed history taking, height, weight, blood pressue measurement.
Antenatal check up was done. 5ml of venous blood is drawn for
analysis.
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Fasting  blood samples were taken from 100 pregnant patients with
pre eclampsia and 100 normal pregnant women, admitted  in  Tirunelveli
Medical College Hospital.
The samples were subjected to analysis of lipid profile.
The patients were also followed up till delivery to assess the
outcome of both mother and the baby.
Specimen
Freshly collected plasma. Anticoagulant used was EDTA.
Procedure
The lipid profile of the samples were determined using a
semiautomated analyser.
Reagents used :
The following reagents were used for determination of the lipid
values.
Total Cholesterol: Cholesterol Oxidase, Peroxidase
HDL Cholesterol: Phosphotungstate / Magnesium precipitation
LDL Cholesterol: Catalase / cholesterol esterase / cholesterol oxidase
Triglycerides: Glycerol Phosphate oxidase/ Peroxidase
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Reference values of the lab
Total cholesterol: 125 - 200 mgs / dl HDL
HDL : 30 - 65 mgs / dl
Triglycerides : 25 - 200 mgs / dl LDL
LDL : 85 - 130 mgs / dl
VLDL : 5 - 40 mgs / dl.
LIPID PROFILE
DESIRABLE BORDERLINE HIGH
RISK
Cholesterol <200 mg/dl 200-239 mg/dl 240 mg/dl
Triglycerides <150 mg/dl 150-199 mg/dl 200-499
mg/dl
HDL
cholesterol
60 mg/dl 35-45 mg/dl <35 mg/dl
LDL
cholesterol
60-130 mg/dl 130-159 mg/dl 160-189
mg/dl
Cholesterol /
HDL ratio
4.0 5.0 6.0
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RESULTS OF THE STUDY
The  women with pre eclampsia were grouped as  Group  I (Study
Group).
The normal pregnant women were grouped as Group II (Control
Group). The results of the study were analysed as follows
The results were analysed between group I and group II according
to the age distribution, booked / unbooked status, obstetrics score, history
of PIH in the previous pregnancy, body  mass  index,  total  cholesterol,
HDL,  VLDL,  LDL,  triglycerides, triglyceride levels.
Data will be analysed using student “T” TEST and significance will
be expressed in p values.
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TABLE - 1
AGE
GROUPS
No. OF
PATIENTS
MEAN AGE
(Yrs) S.D.
S.E. OF
MEAN
GROUP I 100 25.1700 2.816 0.28817
GROUP II 100 24.6100 3.03147 0.30315
t = 1.330; p = 0.182 Not significant
TABLE - 1(a) AGE DISTRIBUTION
AGE IN
YEARS
GROUP I GROUP II
NO.  OF CASES % NO.  OF CASES %
< 20 3 3 6 6
21 – 25 53 53 56 56
26 – 30 42 42 34 34
31 – 35 2 2 4 4
Total 100 100 100 100
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Inference
There is no significant change in the age distribution between the
two groups.
53% of the patients  in Group I and 56% of patients  in Group II
were in the age group of 21 - 25 years.
Only 2%  of patients  in Group I and 4%  of patients  in Group II
were in the age group of 31 - 35 years.
6%
56%
34%
4%
GROUP II
< 20
21 – 25
26 – 30
31 – 35
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TABLE - 2
BOOKED / UNBOOKED
BOOKING
STATUS
GROUP I GROUP II
NO.  OF CASES % NO.  OF CASES %
Booked 92 92 92 92
Unbooked 8 8 8 8
Total 100 100 100 100
p = 100 ; x2    = 0.000                                                         Not significant
BOOKED / UNBOOKED
Fig. 2
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92%
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Inference
The booking status of both the study group and the control group
were the same, 92% being booked and 8% being unbooked.
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TABLE - 3
OBSTETRIC SCORE
GRAVIDA GROUP I GROUP II
NO.  OF CASES % NO.  OF CASES %
1 47 47 51 51
2 42 42 38 38
3 7 7 9 9
4 4 4 2 2
Total 100 100 100 100
Fig. 3
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GROUP I
1 2 3 4
GROUP I
1 2 3 4
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Inference
47%  of patients  in Group I and 51%  of patients  in Group II were
primigravida, while      only      4%       in      Group      I    and      2%
in      Group      II    were Gravida 4.
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TABLE - 4
HISTORY OF PIH IN PREVIOUS PREGNANCY
PIH IN PREVIOUS
PREGNANCY
GROUP I GROUP II
NO.  OF
CASES
% NO.  OF
CASES
%
YES 12 12 5 5
NO 88 88 95 95
Total 100 100 100 100
p = 0.076 ; x2    = 3.150                                             Not significant
Chi-square = 3.150
HISTORY OF PIH IN PREVIOUS PREGNANCY
Fig. 4
0
10
20
30
40
50
60
70
80
90
100
GROUP I GROUP II
YES NO
55
Inference
12%  of patients  in group I and 5%  of patients  in Group II had
H/o  PIH in the previous pregnancy.
YES
12%
NO
88%
GROUP I
YES
NO
YES
5%
NO
95%
GROUP II
YES
NO
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TABLE - 5
COMPARISON OF BMI BETWEEN THE TWO GROUPS
GROUP NO.  OF
CASES
MEAN BMI S.D. S.E. OF MEAN
GROUP I 100 26.2080 3.39511 0.33951
GROUP II 100 24.710 2.52602 0.25260
p = 0.001 Significant
Inference
It is found that, patients with pre eclampsia(Group I) had high
BMI than their normal counterparts (Group II)
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TABLE - 6
TOTAL CHOLESTEROL LEVELS
GROUPS NO.  OF
CASES
MEAN
(mg%)
S.D. S.E. OF MEAN
GROUP I 100 212.6420 53.10793 5.31079
GROUP II 100 173.7015 41.87940 4.18799
p = 0.03 Significant
Inference
The mean total cholesterol level is significantly higher in pre
eclampsia affected mothers in group 1.
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TABLE - 7
HDL LEVELS
GROUPS NO.  OF
CASES
MEAN
(mg%)
S.D. S.E. OF MEAN
GROUP I 100 41.2684 9.35250 0.93525
GROUP II 100 48.0264 9.71615 0.97162
p = 0.04 Significant
Inference
The mean HDL levels are lower in Group I compared to Group II.
59
TABLE - 8
VLDL Levels
GROUPS NO.  OF
CASES
MEAN
(mg %)
S.D. S.E. OF MEAN
GROUP I 100 48.9432 18.38757 1.83876
GROUP II 100 35.5844 11.18140 1.11814
p = 0.04; T = 6.208                                                                Significant
Inference
The mean VLDL values are significantly higher in Group I
compared to Group II.
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TABLE - 9
TGL Levels
GROUPS NO.  OF
CASES
MEAN
(mg %)
S.D. S.E. OF
MEAN
GROUP I 100 220.4673 62.97049 6.29705
GROUP II 100 169.2040 56.92760 5.69276
p = 0.035; t = 6.039                                                                 Significant
Inference
The mean triglyceride  levels show a significant  rise  in Group I
compared to that of Group II.
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TABLE - 10
LDL Levels
GROUPS NO.  OF
CASES
MEAN
(mg%)
S.D. S.E. OF MEAN
GROUP I 100 135.2441 45.83614 4.58361
GROUP II 100 101.674 38.76126 3.87613
p = 0.045; T = 5.592                                                                Significant
Inference
The mean LDL levels are also increased in Group I compared to
that of Group II in a significant manner.
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TABLE - 11
MODE OF DELIVERY
MODE OF
DELIVERY
GROUP I GROUP II
NO.  OF CASES % NO.  OF CASES %
Vaginal 65 65 69 69
LSCS 35 35 31 31
TOTAL 100 100 100 100
MODE OF DELIVERY
Fig. 5
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Inference
65% of patients  in Group I and 69% of patients  in Group II had
normal vaginal delivery
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TABLE - 12
CORRELATION BETWEEN BMI & TGLS
GROUP I
BMI NO.  OF
CASES
MEAN OF
TGLS (mg%)
S.D. S.E. OF MEAN
Normal 62 199.3725 53.74081 6.82509
High  /
OBESE
37 254.0874 63.4071 10.42795
p = 0.02 Significant
GROUP II
BMI NO.  OF
CASES
MEAN OF
TRIGLYCERIDES (mg %)
S.D. S.E. OF
MEAN
Normal 82 161.6781 51.8977 5.80234
High     /
OBESE
18 203.5611 69.93061 16.01140
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p = 0.025; t = 2.915                                                                 Significant
Inference :
It  is found that the obese patients  or the patients  with  high BMI
in Group I had elevated triglycerides than those with normal BMI in the
same group.
Similarly,  the patients  with  high  BMI /  obese patients  in
Group  II also  had elevated triglycerides than the normal.
TABLE - 13
NON OBESE GROUP
GROUPS NON
OBESE
MEAN TGL
(mg %)
S.D. S.E. OF
MEAN
GROUP I 62 127.8315 44.97383 5.71168
GROUP II 81 96.9215 36.13983 4.01554
p = 0.03; t = 4.557 Significant
TABLE - 13 (a) OBESE GROUP
GROUPS OBESE MEAN TGL
(mg %)
S.D. S.E. OF MEAN
GROUP I 37 254.0874 63.43071 10.42795
GROUP II 18 203.5611 67.93061 16.01140
Variance - 25 - F = 0.676;
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Significant = 0.415
2 tailed = 0.009 p = 0.009
Inference :
Among  the  non  obese  group,  the  pre eclampsia patients   in
Group  I  had  increased triglycerides compared to the normal women in
Group II.
Among the obese group also, the mean triglyceride values were
higher in patients with pre eclampsia compared to the normotensive
pregnant women.
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DISCUSSION
In our study, it is found that there is no significant change in age
distribution between the two groups.
Our study, similar to that by Ray  et al., (2006) shows that the mean
triglyceride concentration was significantly  higher among the
preeclamptic cases than among the unaffected controls.24  What might
hypertriglyceridemia predispose a woman to preeclampsia, if there truly
exists a causal relationship? A likely factor is the higher risk of placental
vasculopathy. Persons with the metabolic syndrome of which
hypertriglyceridemia  is  a  major  feature, display  evidence  of  chronic
inflammation, hypercoagulability and endothelial dysfunction.
Our study similar to Carl Hubel et al., (1995) shows that
triglycerides  and free fatty acids are increased  in preeclampsia.5   Their
study correlated the interaction  of the lipid peroxidation metabolite,
malondialdehyde to endothelial cell dysfunction in preeclampsia.
However the effects of malondialdehyde are not included in our study.
The study by Ray  et al., (2006) concluded that there exists a
correlation between obesity and the risk of preeclampsia.24   Our study
also shows that women with elevated BMI in both the control and the PIH
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groups had elevated levels of triglycerides and LDL cholesterol. The
current study also shows hypertriglyceridemia associated with maternal
obesity. Maternal obesity, diabetes mellitus and chronic hypertension, the
major features of the metabolic syndrome are positively correlated with
the development of preeclampsia in many studies.
The study by Barden, et al., (1999) shows that regardless of parity
women with preeclampsia  had elevated BMI during  pregnancy
compared with  women who  had normotensive pregnancies and
triglycerides were significantly elevated in these women and the levels of
triglycerides  after 6 weeks of delivery were found to the decreased. 2
However in our study, the levels of postpartum triglycerides were not
measured.
Our study similar to Sattar  et al., (1997) shows the elevated levels
of cholesterol and trigycerides.26  Kaaja et al., (1995) has found high
plasma triglycerides and low HDL concentrations in women with
preeclampsia and gestational hypertension.12  In our study though there
is elevated level of cholesterol, and triglycerides, the HDL level is found
to be normal.
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This study shows that lipid abnormalities can lead to endothelial cell
dysfunction and vascular damage, thus playing a role in the pathogenesis
of preeclampsia.
The  National  Heart  Foundation     of  Australia   found  increased
levels  of  F2 Isoprotane  in  patients  with  increased  LDL and  triglyceride
concentrations.  Further studies are required in finding the association of
F2  Isoprotanes with preeclampsia. They also found significantly reduced
HDL levels in preeclamptic patients while in our study the levels of HDL
were normal. Further more studies are thus required in determining the
association between HDL levels and predisposition to preeclampsia.
Bendomir  et al.,  (1997)  studied that lipoprotein  subfraction
concentrations are higher in preeclampsia.3   In our study, the lipoprotein
subfractions were not studied. Further studies are required to find the
effect of lipoprotein subfractions in pregnancy.
Anceschi et al.,  (1992)  found increased cholesterol /  phospholipid
ratio of the erythrocyte membrane in women with  pregnancy induced
hypertension.1   In  our study, the levels of the membrane phospholipids
were not measured.
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Dempsey et al., (2004) found that women who were small at birth
and became overweight in adulthood had an unfavourable lipid profile.7
But the subjects in our study were  not  aware of  their  birth  weight.
Hence  this  association  factor  could  not  be correlated in our study.
Our  study similar to that by  Kokia et al.,  (1999)  shows
significantly  elevated levels of triglycerides in the women with pregnancy
induced hypertension.15
Thus, the adverse lipid profile found in the hypertensive  pregnant
patients  could be associated with the enhancement of pathological lipid
deposition  in the predisposed vessels such as uterine arteries.
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COMPARISON OF THE LIPID PROFILE ANALYSIS IN VARIOUS
STUDIES
TGLS LDL HDL
Ray et al. ↑ - -
Carl Hubel et al ↑ - -
Sattar et al ↑ ↑ -
Kaaja et al ↑ ↑ ↓
Our study ↑ ↑ ↓
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SUMMARY
1. There is no significant change in the age distribution between the two
groups. 53% of the patients in Group I and 56% of patients in Group II
were in the age group of 21 - 25 years. Only  2% of patients in Group
I and 4% of patients in Group II were in the age group of 31 - 35 years.
2. The booking  status of both the study group and the control group were
the same, 92% being booked and 8% being unbooked.
3. 47% of patients in Group I and 51% of patients in Group II were
primigravida, while only 4% in Group I and 2% in Group II were
Gravida 4.
4. 12%  of  patients  in group I and 5%  of  patients  in Group  II had H/o
PIH  in the previous pregnancy.
5. It is found that, patients  with  pregnancy induced  hypertension
(Group I) had high BMI than their normal counterparts (Group II).
6. The    mean    total    cholesterol    level    is    higher    in    group    I
than    in Group II.
7. The mean HDL levels are higher in Group I compared to Group II.
8. The     mean    VLDL    values     are    higher     in     Group     I
compared    to Group II
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9. The mean triglyceride  levels show a significant rise in Group I
compared to that of Group II.
10. The mean LDL levels are also increased in Group I compared to that
of Group II. (11)65%  of patients  in Group I and 69%  of patients  in
Group II had normal vaginal delivery.
11. It  is found that the obese patients  or the patients  with  high BMI
in Group I had elevated triglycerides than those with normal BMI in
the same group. Similarly,  the patients  with  high  BMI /  Obese
patients  in  Group  II also  had elevated triglycerides than the normal,
in Group II.
12. Among the non obese group, the PIH patients in Group I had
increased triglycerides compared to the normal women in Group II.
Among the obese group also, the mean triglyceride values were higher
in patients with  pregnancy induced  hypertension  compared to the
normotensive  pregnant women.
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CONCLUSION
Analysing and comparing  the results between the study group and
the control group, it was concluded that :
 53% of the study group were in the age group of 21 - 25 years.
 47% of the study group were primigravida.
 BMI was elevated in the Pre eclampsia group.
 Total cholesterol values are significantly increased in pre
eclampsia group.
 Triglycerides and LDL were elevated in the Pre eclampsia group,
compared to the control group.
 HDL is decreased in pre eclamptic group.
 The obese group with elevated BMI had elevated triglyceride
levels.
Hyperestrogenism in pregnancy is responsible for
hypertriglyceridemia in pregnancy. Oestrogen induces hepatic bio
synthesis of endogenous triglyceride which is arried by VLDL. This
increased triglyceride in pre eclampsia is likely to be deposited in
predisposed vessels like uterine artery and contributes to endothelial
dysfunction directly or indirectly through small dense LDL. Increased
76
triglyceride and its decreased clearance clearly helps in understanding
the pathological process of pre eclampsia. Moreover
hypertriglyceridemia is also associated with hypercoagulability.
Thus  there exists  a  consistent  positive  association  between
elevated maternal triglyceride and the risk of preeclampsia. Given that the
maternal  hypertriglyceridemia is a  common feature of  the metabolic
syndrome, interventional  studies are needed to determine whether pre -
pregnancy weight reduction and dietary modification can lower the risk
of preeclampsia.
The matter of whether triglycerides share a causative relationship
with preeclampsia  should  be  expanded to  the  study  of  other lipoprotein
particles  and microparticles,  as well as a detailed  analysis of the
microvascular  bed of the delivered placenta. The collection  of  blood
specimens in  early pregnancy measuring concentrations of insulin,
glucose and inflammatory markers, alongside anthropometrics
assessment and then followed by a thorough assessment of clinical
outcomes through a large cohort study might optimally address the role of
triglycerides and the metabolic syndrome in the causation of
preeclampsia.
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Clearly, there is a need to establish whether preconceptional dietary
modification, such as adoption of a Mediterranean  diet among obese
women, can reduce the future risk of preeclampsia and other placenta
mediated diseases, including.
HDL is decreased due to hypo oestrogenic state in pre-eclampsia.
Despite hypooestrogenism , insulin resistance in hypertensive disorders
favour more towards the reduction in HDL. A tendency to lower serum
lipoprotein fractions in women with toxemia and in third trimester of
pregnancy is proven in many earlier studies.
It is therefore essential that  serum lipid profile should be
estimated during routine ante natal care, as it help in predicting pre
eclampsia and preventing the major complications of pre-eclampsia
before it manifests. Also lipid profile have to be monitored throughout the
pregnancy in high risk population as it would be a better predictor of pre
eclampsia.
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PROFORMA
Name : Age                                                        :
IP No. : Obstetric Score :
Booking Status : Socio Economic Status :
H/o PIH in Previous Pregnancy :
Diet History : Vegetarian
- NonVegetarian
Taking more than two serves per week
Taking less than two serves per
week. Family History :
Religion :
Chief Complaints :
H/o Swelling of legs / oliguria
Any H/o Headache / Blurring of vision / Vomiting / Epigastric pain. Any
H/o DM/HT/Bronchial Asthma /Cardiac/Thyroid Disease.General
Examination
Anaemia Jaundice Pedal edema JVP
Vitals:
PR:
BP: RR:
Any symptoms of imminent eclampsia. Systemic examination:
Respiratory system. Cardiovascular System. CNS:
Obstetric Examination
Investigations:
Albumin
Urine Sugar
Deposits
24 hrs urinary proteins
VDRL NVP
Blood grouping & typing
CBC - Platelet Count Bleeding time Clotting time
Blood Sugar
Urea
Sr. Creatinine Sr.Uric acid. Sr.Fibrinogen
Liver function Tests
Lipid Profile
Fundus Examination
Obstetric Ultrasound
NehahspfSf;F mwptpg;G kw;Wk; xg;Gjy; gbtk; 
(kUj;Jt Ma;tpy; gq;Nfw;gj;w;F) 
Ma;T nra;ag;gLk; jiyg;G:  
gq;F ngWthpd; ngaH: 
gq;F ngWthpd; taJ: 
  gq;F ngWth; 
,jid  
Fwpf;fTk; 
1.  ehd; NkNy Fwpg;gpl;Ls;s kUj;Jt Ma;tpd; tptuq;fis gbj;J 
Ghpe;J nfhz;Nld;. vd;Dila re;Njfq;fis Nfl;fTk;> 
mjw;fhd jFe;j tpsf;fq;fis ngwTk; tha;g;gspf;fg;gl;Ls;sJ 
vd mwpe;J nfhz;Nld;. 
 
2.  ehd; ,t;tha;tpy; jd;dpr;irahf jhd; gq;Nfw;fpNwd;. ve;j 
fhuzj;jpdhNyh ve;j fl;lj;jpYk;> ve;j rl;l rpf;fYf;Fk; 
cl;glhky; ehd; ,t;tha;tpy; ,Ue;J tpyfp nfhs;syhk; vd;Wk; 
mwpe;J nfhz;Nld;. 
 
3.  ,e;j Ma;T rk;ge;jkhfNth> ,ij rhHe;J NkYk; Ma;T 
Nkw;fhs;Sk; NghJk; ,e;j Ma;tpy; gq;FngWk; kUj;JtH 
vd;Dila kUj;Jt mwpf;iffis ghHg;gjw;F vd; mDkjp 
Njitapy;iy vd mwpe;J nfhs;fpNwd;. ehd; Ma;tpy; ,Ue;J 
tpyfpf; nfhz;lhYk; ,J nghUe;Jk;; vd mwpfpNwd;. 
 
4.  ,e;j Ma;tpd; %yk; fpilf;Fk; jftiyNah> KbitNah 
gad;gLj;jpf; nfhs;s kWf;f khl;Nld;. 
 
5.  ,e;j Ma;tpy; gq;F nfhs;s xg;Gf; nfhs;fpNwd; vdf;F 
nfhLf;fg;gl;lmwpTiufspd; gb ele;J nfhs;tJld;> Ma;it 
Nkw;nfhs;Sk; kUj;Jt mzpf;F cz;ikAld; ,Ug;Ngd; vd;W 
cWjpaspf;fpNwd;. vd; cly; eyk; ghjpf;fg;gl;lhNyh> my;yJ 
vjpHghuhj> tof;fj;jpw;F khwhd Neha;Fwp njd;gl;lhNyh clNd 
,ij kUj;Jt mzpaplk; njhptpg;Ngd; vd cWjp mspf;Nwd;. 
 
 
gq;Nfw;gthpd; ifnahg;gk; / .................................................... ,lk; ........................................... 
fl;iltpuy; Nuif 
gq;Nfw;gthpd; ngaH kw;Wk; tpyhrk; ........................................................................................ 
Ma;thshpd; ifnahg;gk; /...................................................... ,lk; ............................................ 
Ma;thshpd; ngaH ......................................................................................................................... 
ikak; ...............................................................................................................................................  
fy;tpawpT ,y;yhjtw;F (ifNuif itj;jtHfSf;F) ,J mtrpak; Njit 
rhl;rpapd; ifnahg;gk; /...................................................... ,lk; ................................................ 
ngaH kw;Wk; tpyhrk; ................. ................................................................................................... 
S.No Age Bookingstatus
Obstetric
Code
PIH in previous
Pregnancy
mean
BMI
T.Cholestero
l
HDL
Level
VLDL
Level
TGL
level
LDL
level
1 18 Booked Primi No 26.5 250 50 52 250 140
2 22 Booked G4A3 Yes 27.5 230 52 50 230 141
3 23 Booked Primi No 28.4 200 54 55 200 138
4 22 Booked G2P1L1 No 28.1 172 50 51 172 137
5 24 Booked G3P2L2 No 26 158 48 49 158 180
6 25 Unbooked G3P2L2 No 24.1 202 49 48 202 136
7 26 Booked Primi No 24 230 50 49 230 134
8 17 Booked G2P1L1 No 23 235 48 49 235 130
9 28 Booked Primi No 18.4 240 49 50 240 121
10 27 Booked G4P3L3 No 24.1 190 59 56 200 131
11 23 Booked Primi No 25.1 182 60 59 182 127
12 24 Booked G2A1 Yes 28 185 55 56 185 103
13 22 Booked G2P1L1 No 29.4 192 40 41 192 123
14 19 Booked Primi No 21.2 194 41 40 194 124
15 21 Unbooked G3P2L2 No 22 215 42 42 215 136
16 22 Booked Primi No 23.4 232 45 43 282 141
17 23 Booked G2P1L1 No 25 280 44 44 230 142
18 24 Booked Primi No 26.1 149 48 49 149 146
19 25 Booked G2P1L1 No 27.4 189 49 48 189 151
20 32 Booked Primi No 28.9 212 50 50 212 136
21 21 Unbooked G4P3L3 No 27.6 220 52 51 220 129
22 24 Booked Primi No 26.9 232 52 53 232 131
23 26 Booked G2A1 Yes 28 210 52 53 210 135
24 28 Booked G3P2L2 No 26.8 194 54 54 194 136
25 29 Booked G2P1L1 No 28.4 190 56 55 190 170
Case
26 30 Booked G2P1L0 No 30.5 184 48 49 184 121
27 25 Booked Primi No 26.1 192 42 40 192 136
28 21 Booked G2P1L1 Yes 27 199 48 47 199 139
29 24 Booked G2P1L1 No 26 168 46 47 168 143
30 23 Booked Primi No 19.6 152 40 41 152 147
31 24 Booked G2P1L1 No 34.5 190 41 42 190 118
32 30 Booked Primi No 25 285 40 40 205 129
33 26 Booked Primi No 26.5 224 50 49 224 129
34 28 Booked G2P1L1 No 27.5 240 52 50 240 120
35 22 Booked Primi No 28.4 234 54 54 234 147
36 23 Booked G2P1L1 No 28.1 239 50 50 239 143
37 24 Booked Primi No 26 280 48 49 280 139
38 21 Booked G2A1 Yes 24.1 294 49 50 294 136
39 22 Booked Primi No 24.5 280 50 49 280 121
40 27 Booked Primi No 24 192 48 49 192 170
41 27 Booked G2P1L1 No 23.5 173 49 48 73 136
42 28 Booked G2P1L1 No 18.4 293 55 56 293 135
43 24 Unbooked G2P1L1 No 24.1 218 60 59 218 131
44 25 Booked Primi No 25.1 249 55 54 249 129
45 21 Booked Primi No 28 322 40 41 322 136
46 22 Booked G2P1L1 No 29.4 289 41 39 289 135
47 23 Booked Primi No 21.2 194 42 38 194 131
48 29 Booked G2P1L1 Yes 22.5 184 45 37 184 129
49 28 Booked Primi No 23.4 281 44 45 281 136
50 24 Booked G2P1L1 No 28.5 294 48 48 294 151
51 29 Booked G4P3L3 No 26.1 280 49 48 280 146
52 25 Unbooked Primi No 29.4 270 50 52 270 142
53 24 Booked G2P1L1 No 28.9 182 52 53 182 141
54 28 Booked Primi No 29.6 184 52 54 184 146
55 21 Booked Primi No 26.9 156 54 55 156 124
56 26 Booked G2P1L1 No 28 190 52 58 190 123
57 24 Booked G2P1L1 Yes 26.8 148 56 45 148 103
58 27 Booked Primi No 28.4 194 48 49 194 127
59 25 Booked Primi No 30.5 190 42 40 190 131
60 29 Booked Primi No 28.1 185 48 46 185 121
61 21 Unbooked G2P1L1 No 27.5 180 46 49 180 130
62 28 Booked G2P1L1 Yes 28.5 170 40 41 170 134
63 22 Booked Primi No 19.6 180 41 42 180 136
64 29 Booked G2A1 No 34 185 40 40 185 180
65 21 Booked Primi No 25.5 190 48 39 190 140
66 30 Booked Primi No 27.3 210 50 52 285 129
67 29 Booked G2P1L1 No 28.4 218 52 54 190 120
68 30 Booked Primi No 25.1 224 54 57 152 147
69 21 Booked G2P1L1 No 26.5 240 50 50 168 143
70 26 Booked Primi No 27.5 234 48 47 199 139
71 22 Booked Primi No 28.4 239 49 48 192 136
72 28 Booked G2P1L1 No 28.1 280 50 51 184 121
73 27 Unbooked G3P2L2 No 28 294 48 52 190 170
74 25 Booked G2P1L1 No 24.1 280 49 49 194 136
75 30 Booked G3P2L2 No 24.5 192 55 60 260 139
76 25 Booked G2A1 Yes 23.5 173 60 51 322 131
77 27 Booked Primi No 18.4 293 55 54 220 129
78 28 Booked Primi No 24.1 218 40 40 212 136
79 25 Booked G2A1 No 25.1 249 41 49 189 139
80 29 Booked G2P1L1 No 28 322 42 43 240 131
81 24 Booked Primi Yes 29.9 289 49 45 230 129
82 26 Booked G2P1L1 No 21.2 184 44 48 282 136
83 27 Booked Primi No 24.5 184 48 49 215 151
84 21 Booked Primi No 23.4 281 49 51 294 146
85 28 Booked G2P1L1 No 25 284 50 54 192 142
86 29 Booked G2P1L1 No 26.1 280 52 55 185 141
87 21 Unbooked Primi No 27.4 260 52 51 182 136
88 30 Booked G2A1 Yes 28.9 182 52 59 260 124
89 22 Booked G3P2L2 No 29.6 180 54 48 230 123
90 27 Booked Primi No 26.9 154 56 59 236 103
91 28 Booked Primi No 28 190 48 48 230 127
92 24 Booked Primi No 26.8 148 42 47 202 131
93 22 Booked G2P1L1 No 28.4 194 48 40 158 121
94 25 Booked Primi No 30.5 190 46 41 172 130
95 34 Booked G2P1L1 No 26.1 185 40 48 200 134
96 22 Booked G2A1 No 27 180 41 47 230 136
97 23 Booked Primi No 28 170 40 42 250 180
98 21 Booked G2P1L1 Yes 19.6 180 48 41 212 140
99 30 Booked Primi No 34 185 47 44 221 141
100 26 Booked Primi No 25.5 190 48 49 220 137
S.No Age Bookingstatus
Obstetric
Code
PIH in previous
Pregnancy
mean
BMI
T.Cholestero
l
HDL
Level
VLDL
Level
TGL
level
LDL
level
1 18 Booked Primi No 26.4 138 40 32 134 101
2 32 Booked Primi No 25 152 38 33 148 102
3 23 Booked Primi No 24.1 146 37 32 142 98
4 21 Unbooked G4P3L3 No 23 160 29 34 156 96
5 22 Booked G2P1L2 No 24.2 162 42 33 158 99
6 28 Booked Primi Yes 26.2 184 33 35 180 96
7 16 Booked G2P1L1 No 27 180 34 36 186 91
8 31 Booked Primi No 24.2 172 36 37 168 93
9 23 Booked Primi No 24.6 200 37 35 196 121
10 29 Booked G2P1L1 No 27 190 38 34 186 118
11 24 Booked Primi No 35 180 39 38 176 108
12 19 Booked Primi No 28 176 46 35 174 108
13 25 Booked G2P1L1 No 23 148 47 37 144 107
14 21 Booked G2P1L1 No 21.1 156 46 40 152 105
15 30 Booked Primi No 28 180 38 41 176 101
16 22 Unbooked G4P3L3 No 27 180 39 33 172 99
17 23 Booked Primi No 25.5 170 38 34 160 91
18 26 Booked G2P1L1 No 26 168 49 35 161 90
19 24 Booked Primi No 27 162 50 39 153 88
20 27 Booked Primi No 21 152 39 40 140 101
21 19 Booked Primi No 20 140 36 41 150 104
22 33 Booked G2P1L1 No 18.5 152 47 30 151 94
23 25 Booked Primi No 24 160 48 29 170 94
24 28 Booked G2P1L1 Yes 25.5 173 47 33 169 98
25 29 Booked Primi No 26 172 46 35 184 99
CONTROL
26 21 Booked Primi No 27.5 188 38 40 190 98
27 23 Booked Primi No 23 192 49 43 188 120
28 29 Unbooked G3P2L2 No 21.5 190 50 41 180 124
29 22 Booked G2P1L1 No 20 188 47 35 190 108
30 24 Booked Primi No 20.5 190 48 36 218 105
31 25 Booked Primi No 19 228 49 37 224 104
32 30 Booked Primi No 20.8 234 50 40 173 98
33 26 Booked Primi No 26.4 138 58 39 178 96
34 23 Booked Primi No 29 152 40 32 178 96
35 22 Booked G2P1L1 No 30 146 38 33 173 98
36 21 Booked G2A1 No 24 160 37 32 220 104
37 26 Booked G2P1L1 No 23 162 29 34 212 105
38 24 Booked G3P2L2 No 24.2 184 42 33 188 108
39 25 Booked Primi No 26.2 190 33 35 186 124
40 22 Unbooked G2P1L1 Yes 27 172 34 36 188 120
41 27 Booked Primi No 24.2 200 36 37 186 98
42 21 Booked Primi No 24.6 190 37 35 184 99
43 24 Booked G2P1L1 No 27 180 38 34 169 98
44 23 Booked Primi No 35 176 39 33 170 94
45 25 Booked G3P2L2 No 28 148 46 35 151 94
46 28 Booked Primi No 23 156 47 37 150 104
47 22 Booked G2P1L1 No 21.1 180 46 40 140 101
48 21 Booked Primi No 28 180 38 41 153 88
49 23 Booked Primi No 27 170 39 33 161 90
50 29 Booked G2P1L1 No 25.5 168 38 34 160 91
51 24 Booked G2P1L1 No 26 162 49 35 171 99
52 27 Booked Primi No 27 152 50 39 176 101
53 25 Unbooked Primi No 21 140 39 40 152 105
54 30 Booked G3P2L2 No 20 152 36 41 144 107
55 22 Booked Primi No 18.5 160 37 30 174 108
56 23 Booked Primi No 24 173 48 29 176 118
57 21 Booked Primi No 25.5 172 47 33 186 108
58 26 Booked G2A1 No 26 188 46 35 196 121
59 24 Booked Primi No 27.5 192 48 40 168 93
60 25 Booked Primi No 23 190 49 43 184 91
61 22 Booked G3P2L2 No 21.5 188 50 41 180 96
62 27 Booked G2P1L0 Yes 20 190 47 35 158 99
63 21 Booked Primi No 20.5 228 48 36 156 96
64 30 Booked Primi No 19 234 49 37 142 98
65 28 Booked G2P1L1 No 20.8 173 50 40 148 102
66 29 Booked G3P2L2 No 20.8 138 50 39 134 101
67 29 Booked Primi No 19 152 40 32 134 101
68 25 Booked Primi No 20.5 146 38 33 148 102
69 23 Booked Primi No 20 160 37 32 142 98
70 30 Booked Primi No 21.5 162 29 34 156 96
71 21 Booked G2P1L1 No 23 184 42 33 158 99
72 26 Booked G2P1L1 No 27.5 180 33 35 180 96
73 22 Booked Primi No 26 172 34 36 186 91
74 26 Unbooked G3P2L2 No 25.5 200 36 37 168 93
75 24 Booked Primi No 24 190 37 35 196 121
76 23 Booked G2P1L1 No 18.5 180 38 34 186 118
77 27 Booked G2P1L1 No 20 176 39 33 170 108
78 25 Booked Primi No 21 148 46 35 172 107
79 28 Booked G2P1L1 No 27 156 47 37 132 108
80 21 Booked G2P1L1 No 26 180 46 40 152 105
81 28 Booked G2P1L1 No 25.5 180 38 41 176 101
82 22 Booked G2P1L1 No 27 170 39 33 172 99
83 23 Booked Primi No 28 168 38 34 160 91
84 29 Unbooked G3P2L2 Yes 21.1 166 40 35 161 90
85 24 Booked Primi No 23 152 50 39 151 98
86 25 Booked G2P1L1 No 28 140 39 40 139 101
87 30 Booked G2P1L1 No 35 152 36 41 150 104
88 21 Booked G2P1L1 No 27 160 47 30 151 94
89 26 Booked G2P1L1 No 24.6 173 48 29 170 94
90 22 Booked Primi No 24.2 172 47 33 165 98
91 27 Booked G2P1L1 No 27 188 45 35 184 99
92 23 Booked G2P1L0 No 26.2 192 38 40 188 120
93 28 Booked Primi No 24.2 190 49 43 180 124
94 17 Booked G2A1 No 23 188 30 41 190 108
95 29 Booked G2A1 No 24 190 47 35 218 105
96 24 Booked G2P1L1 No 25 228 48 36 224 104
97 30 Unbooked G3P2L2 No 26.4 234 49 37 173 98
98 25 Booked G2P1L1 No 27 173 38 40 169 96
99 34 Booked Primi No 30 174 39 39 168 99
100 18 Booked Primi No 29 174 40 30 167 105








